{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T20:10:32Z","timestamp":1788898232248,"version":"build-2803163510"},"reference-count":49,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,16]],"date-time":"2022-11-16T00:00:00Z","timestamp":1668556800000},"content-version":"vor","delay-in-days":653,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100005160","name":"American Society of Transplantation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005160","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["amjtransplant.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Transplantation"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1111\/ajt.16324","type":"journal-article","created":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T16:40:58Z","timestamp":1601052058000},"page":"475-483","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":82,"title":["Preexisting melanoma and hematological malignancies, prognosis, and timing to solid organ transplantation: A consensus expert opinion statement"],"prefix":"10.1016","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4469-6375","authenticated-orcid":false,"given":"David P.","family":"Al-Adra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Hammel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4280-0842","authenticated-orcid":false,"given":"E. Steve","family":"Woodle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2021-2233","authenticated-orcid":false,"given":"Deborah","family":"Levine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Didier","family":"Mandelbrot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9658-3751","authenticated-orcid":false,"given":"Elizabeth","family":"Verna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0220-8716","authenticated-orcid":false,"given":"Jayme","family":"Locke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"D\u2019Cunha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryjane","family":"Farr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7903-8295","authenticated-orcid":false,"given":"Deirdre","family":"Sawinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piyush K.","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Plichta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandhya","family":"Pruthi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Farr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Carvajal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9703-647X","authenticated-orcid":false,"given":"Fiona","family":"Zwald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Habermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morie","family":"Gertz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Bierman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Don S.","family":"Dizon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carrie","family":"Langstraat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5215-6408","authenticated-orcid":false,"given":"Talal","family":"Al-Qaoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Eggener","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John P.","family":"Richgels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George J.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Geltzeiler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gonzalo","family":"Sapisochin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rocco","family":"Ricciardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1790-6197","authenticated-orcid":false,"given":"Alexander S.","family":"Krupnick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cassie","family":"Kennedy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nisha","family":"Mohindra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David P.","family":"Foley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1776-3680","authenticated-orcid":false,"given":"Kymberly D.","family":"Watt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 2","key":"10.1111\/ajt.16324_bib1","first-page":"3","article-title":"The evaluation of renal transplantation candidates: clinical practice guidelines","volume":"1","author":"Kasiske","year":"2001","journal-title":"Am J Transplant."},{"issue":"7","key":"10.1111\/ajt.16324_bib2","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1097\/TP.0000000000002178","article-title":"Solid organ transplantation in patients with preexisting malignancies in remission: a propensity score matched cohort study","volume":"102","author":"Acuna","year":"2018","journal-title":"Transplantation."},{"issue":"3","key":"10.1111\/ajt.16324_bib3","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/TP.0b013e31829854b7","article-title":"Overall and cause-specific mortality in transplant recipients with a pretransplantation cancer history","volume":"96","author":"Brattstrom","year":"2013","journal-title":"Transplantation."},{"issue":"6","key":"10.1111\/ajt.16324_bib4","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.jamcollsurg.2019.06.001","article-title":"Impact of pre-transplant malignancy on outcomes after kidney transplantation: united network for organ sharing database analysis","volume":"229","author":"Livingston-Rosanoff","year":"2019","journal-title":"J Am Coll Surg."},{"key":"10.1111\/ajt.16324_bib5","series-title":"2019 USRDS Annual Data Report: Epidemiology of Kidney Disease in the United States","year":"2019"},{"issue":"10","key":"10.1111\/ajt.16324_bib6","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1111\/j.1600-0625.2011.01320.x","article-title":"Cyclosporin A inhibits nucleotide excision repair via downregulation of the xeroderma pigmentosum group A and G proteins, which is mediated by calcineurin inhibition","volume":"20","author":"Kuschal","year":"2011","journal-title":"Exp Dermatol."},{"issue":"5","key":"10.1111\/ajt.16324_bib7","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1097\/TP.0000000000000449","article-title":"Association of antibody induction immunosuppression with cancer after kidney transplantation","volume":"99","author":"Hall","year":"2015","journal-title":"Transplantation."},{"issue":"8","key":"10.1111\/ajt.16324_bib8","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1097\/01.TP.0000442773.38510.32","article-title":"Acute rejection, T-cell-depleting antibodies, and cancer after transplantation","volume":"97","author":"Lim","year":"2014","journal-title":"Transplantation."},{"issue":"10","key":"10.1111\/ajt.16324_bib9","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1097\/TP.0b013e3182a203e4","article-title":"Kinetics of homeostatic proliferation and thymopoiesis after rATG induction therapy in kidney transplant patients","volume":"96","author":"Bouvy","year":"2013","journal-title":"Transplantation."},{"issue":"10","key":"10.1111\/ajt.16324_bib10","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1097\/00007890-199711270-00010","article-title":"Persistent long-term changes in lymphocyte subsets induced by polyclonal antibodies","volume":"64","author":"Muller","year":"1997","journal-title":"Transplantation."},{"issue":"4","key":"10.1111\/ajt.16324_bib11","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1111\/ajt.13092","article-title":"ATG-induced accelerated immune senescence: clinical implications in renal transplant recipients","volume":"15","author":"Crepin","year":"2015","journal-title":"Am J Transplant."},{"issue":"6","key":"10.1111\/ajt.16324_bib12","first-page":"472","article-title":"Melanoma staging: evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual","volume":"67","author":"Gershenwald","year":"2017","journal-title":"CA Cancer J Clin."},{"issue":"10","key":"10.1111\/ajt.16324_bib13","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1200\/JCO.2014.56.6018","article-title":"Five-year survival rates for treatment-naive patients with advanced melanoma who received ipilimumab plus dacarbazine in a phase III trial","volume":"33","author":"Maio","year":"2015","journal-title":"J Clin Oncol."},{"issue":"10","key":"10.1111\/ajt.16324_bib14","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1001\/jamaoncol.2019.2187","article-title":"Five-year survival and correlates among patients with advanced melanoma, renal cell carcinoma, or non-small cell lung cancer treated with nivolumab","volume":"5","author":"Topalian","year":"2019","journal-title":"JAMA Oncol."},{"issue":"4","key":"10.1111\/ajt.16324_bib15","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1093\/annonc\/mdz011","article-title":"Five-year survival outcomes for patients with advanced melanoma treated with pembrolizumab in KEYNOTE-001","volume":"30","author":"Hamid","year":"2019","journal-title":"Ann Oncol."},{"issue":"7","key":"10.1111\/ajt.16324_bib16","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1056\/NEJMoa1904059","article-title":"Five-year outcomes with dabrafenib plus trametinib in metastatic melanoma","volume":"381","author":"Robert","year":"2019","journal-title":"N Engl J Med."},{"issue":"19","key":"10.1111\/ajt.16324_bib17","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1056\/NEJMoa1802357","article-title":"Adjuvant pembrolizumab versus placebo in resected stage III melanoma","volume":"378","author":"Eggermont","year":"2018","journal-title":"N Engl J Med."},{"key":"10.1111\/ajt.16324_bib18","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1200\/EDBK_201131","article-title":"Combination immunotherapy development in melanoma","volume":"38","author":"Eggermont","year":"2018","journal-title":"Am Soc Clin Oncol Educ Book."},{"issue":"19","key":"10.1111\/ajt.16324_bib19","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1056\/NEJMoa1709030","article-title":"Adjuvant nivolumab versus ipilimumab in resected stage III or IV melanoma","volume":"377","author":"Weber","year":"2017","journal-title":"N Engl J Med."},{"issue":"35","key":"10.1111\/ajt.16324_bib20","doi-asserted-by":"crossref","first-page":"3441","DOI":"10.1200\/JCO.18.01219","article-title":"Longer follow-up confirms relapse-free survival benefit with adjuvant dabrafenib plus trametinib in patients with resected BRAF V600-mutant stage III melanoma","volume":"36","author":"Hauschild","year":"2018","journal-title":"J Clin Oncol."},{"issue":"8","key":"10.1111\/ajt.16324_bib21","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/S1470-2045(10)70024-3","article-title":"Transmission of donor melanoma by organ transplantation","volume":"11","author":"Strauss","year":"2010","journal-title":"Lancet Oncol."},{"issue":"6","key":"10.1111\/ajt.16324_bib22","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1016\/j.jaad.2019.07.005","article-title":"Immune checkpoint inhibitor therapy in solid organ transplant recipients: a patient-centered systematic review","volume":"82","author":"Fisher","year":"2020","journal-title":"J Am Acad Dermatol."},{"issue":"5 Suppl 1","key":"10.1111\/ajt.16324_bib23","first-page":"109","article-title":"Evaluation of the candidate with a previous malignancy","volume":"2","author":"Penn","year":"1996","journal-title":"Liver Transpl Surg."},{"issue":"3","key":"10.1111\/ajt.16324_bib24","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.jaad.2008.05.015","article-title":"Outcomes of melanoma in recipients of solid organ transplant","volume":"59","author":"Dapprich","year":"2008","journal-title":"J Am Acad Dermatol."},{"issue":"9","key":"10.1111\/ajt.16324_bib25","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1111\/j.1600-6143.2008.02326.x","article-title":"Melanoma in organ transplant recipients: clinicopathological features and outcome in 100 cases","volume":"8","author":"Matin","year":"2008","journal-title":"Am J Transplant."},{"issue":"2","key":"10.1111\/ajt.16324_bib26","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/DSS.0000000000000602","article-title":"Melanoma outcomes in transplant recipients with pretransplant melanoma","volume":"42","author":"Arron","year":"2016","journal-title":"Dermatol Surg."},{"issue":"11","key":"10.1111\/ajt.16324_bib27","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1038\/jid.2015.312","article-title":"Melanoma risk and survival among organ transplant recipients","volume":"135","author":"Robbins","year":"2015","journal-title":"J Invest Dermatol."},{"issue":"2","key":"10.1111\/ajt.16324_bib28","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/ajt.13593","volume":"16","author":"Zwald","year":"2016","journal-title":"Am J Transplant."},{"issue":"14","key":"10.1111\/ajt.16324_bib29","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1056\/NEJMoa1709684","article-title":"Overall survival with combined nivolumab and ipilimumab in advanced melanoma","volume":"377","author":"Wolchok","year":"2017","journal-title":"N Engl J Med."},{"key":"10.1111\/ajt.16324_bib30","unstructured":"National Comprehensive Cancer Network (NCCN). B-Cell Lymphomas. V3.2020. https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/b-cell.pdf. Accessed August 6, 2020"},{"issue":"2","key":"10.1111\/ajt.16324_bib31","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/ajh.24223","article-title":"Personalized risk prediction for event-free survival at 24 months in patients with diffuse large B-cell lymphoma","volume":"91","author":"Maurer","year":"2016","journal-title":"Am J Hematol."},{"issue":"8","key":"10.1111\/ajt.16324_bib32","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1093\/annonc\/mdy203","article-title":"Progression-free survival at 24 months (PFS24) and subsequent outcome for patients with diffuse large B-cell lymphoma (DLBCL) enrolled on randomized clinical trials","volume":"29","author":"Maurer","year":"2018","journal-title":"Ann Oncol."},{"issue":"11","key":"10.1111\/ajt.16324_bib33","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1002\/ajh.24492","article-title":"Early event status informs subsequent outcome in newly diagnosed follicular lymphoma","volume":"91","author":"Maurer","year":"2016","journal-title":"Am J Hematol."},{"issue":"2","key":"10.1111\/ajt.16324_bib34","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1200\/JCO.18.00400","article-title":"Cause of death in follicular lymphoma in the first decade of the rituximab era: a pooled analysis of French and US cohorts","volume":"37","author":"Sarkozy","year":"2019","journal-title":"J Clin Oncol."},{"issue":"6","key":"10.1111\/ajt.16324_bib35","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1200\/JCO.2012.43.4803","article-title":"Randomized phase III trial of ABVD versus Stanford V with or without radiation therapy in locally extensive and advanced-stage Hodgkin lymphoma: an intergroup study coordinated by the Eastern Cooperative Oncology Group (E2496)","volume":"31","author":"Gordon","year":"2013","journal-title":"J Clin Oncol."},{"issue":"36","key":"10.1111\/ajt.16324_bib36","doi-asserted-by":"crossref","first-page":"4019","DOI":"10.1200\/JCO.2017.73.8195","article-title":"International assessment of event-free survival at 24 months and subsequent survival in peripheral T-cell lymphoma","volume":"35","author":"Maurer","year":"2017","journal-title":"J Clin Oncol."},{"issue":"4","key":"10.1111\/ajt.16324_bib37","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1111\/bjh.16425","article-title":"Minimal relapse risk and early normalization of survival for patients with Burkitt lymphoma treated with intensive immunochemotherapy: an international study of 264 real-world patients","volume":"189","author":"Jakobsen","year":"2020","journal-title":"Br J Haematol."},{"issue":"24","key":"10.1111\/ajt.16324_bib38","doi-asserted-by":"crossref","first-page":"3959","DOI":"10.1200\/JCO.2008.21.2704","article-title":"Brief report: natural history of individuals with clinically recognized monoclonal B-cell lymphocytosis compared with patients with Rai 0 chronic lymphocytic leukemia","volume":"27","author":"Shanafelt","year":"2009","journal-title":"J Clin Oncol."},{"issue":"3","key":"10.1111\/ajt.16324_bib39","doi-asserted-by":"crossref","first-page":"293","DOI":"10.6004\/jnccn.2017.0030","article-title":"NCCN guidelines insights: chronic lymphocytic leukemia\/small lymphocytic lymphoma, version 1.2017","volume":"15","author":"Wierda","year":"2017","journal-title":"J Natl Compr Canc Netw."},{"issue":"6","key":"10.1111\/ajt.16324_bib40","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S1470-2045(16)30029-8","article-title":"An international prognostic index for patients with chronic lymphocytic leukaemia (CLL-IPI): a meta-analysis of individual patient data","volume":"17","year":"2016","journal-title":"Lancet Oncol."},{"issue":"1","key":"10.1111\/ajt.16324_bib41","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/bjh.13759","article-title":"Solid organ transplant in individuals with monoclonal B-cell lymphocytosis and chronic lymphocytic leukaemia","volume":"174","author":"Strati","year":"2016","journal-title":"Br J Haematol."},{"issue":"4","key":"10.1111\/ajt.16324_bib42","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.bbmt.2017.01.076","article-title":"Impact of post-transplant response and minimal residual disease on survival in myeloma with high-risk cytogenetics","volume":"23","author":"Chakraborty","year":"2017","journal-title":"Biol Blood Marrow Transplant."},{"issue":"25","key":"10.1111\/ajt.16324_bib43","doi-asserted-by":"crossref","first-page":"2900","DOI":"10.1200\/JCO.2016.69.2517","article-title":"Depth of response in multiple myeloma: a pooled analysis of three PETHEMA\/GEM clinical trials","volume":"35","author":"Lahuerta","year":"2017","journal-title":"J Clin Oncol."},{"issue":"5","key":"10.1111\/ajt.16324_bib44","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1053\/j.ajkd.2016.11.024","article-title":"Acute kidney allograft rejection precipitated by lenalidomide treatment for multiple myeloma","volume":"69","author":"Lum","year":"2017","journal-title":"Am J Kidney Dis."},{"issue":"2","key":"10.1111\/ajt.16324_bib45","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.transproceed.2018.10.005","article-title":"Kidney transplantation after hematopoietic cell transplantation in plasma cell dyscrasias: case reports","volume":"51","author":"Dominguez-Pimentel","year":"2019","journal-title":"Transplant Proc."},{"issue":"10","key":"10.1111\/ajt.16324_bib46","doi-asserted-by":"crossref","first-page":"2900","DOI":"10.1111\/ajt.15487","article-title":"Delayed autologous stem cell transplantation following cardiac transplantation experience in patients with cardiac amyloidosis","volume":"19","author":"Trachtenberg","year":"2019","journal-title":"Am J Transplant."},{"issue":"2","key":"10.1111\/ajt.16324_bib47","doi-asserted-by":"crossref","first-page":"380","DOI":"10.5500\/wjt.v6.i2.380","article-title":"Long term outcomes of cardiac transplant for immunoglobulin light chain amyloidosis: the Mayo Clinic experience","volume":"6","author":"Grogan","year":"2016","journal-title":"World J Transplant."},{"issue":"2","key":"10.1111\/ajt.16324_bib48","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.kint.2018.09.021","article-title":"Long-term outcome of kidney transplantation in AL amyloidosis","volume":"95","author":"Angel-Korman","year":"2019","journal-title":"Kidney Int."},{"issue":"7","key":"10.1111\/ajt.16324_bib49","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1182\/blood-2012-04-423046","article-title":"Five-group cytogenetic risk classification, monosomal karyotype, and outcome after hematopoietic cell transplantation for MDS or acute leukemia evolving from MDS","volume":"120","author":"Deeg","year":"2012","journal-title":"Blood."}],"container-title":["American Journal of Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ajt.16324","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/ajt.16324","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522083745?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522083745?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ajt.16324","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:30:20Z","timestamp":1761629420000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1600613522083745"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":49,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["S1600613522083745"],"URL":"https:\/\/doi.org\/10.1111\/ajt.16324","relation":{},"ISSN":["1600-6135"],"issn-type":[{"value":"1600-6135","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preexisting melanoma and hematological malignancies, prognosis, and timing to solid organ transplantation: A consensus expert opinion statement","name":"articletitle","label":"Article Title"},{"value":"American Journal of Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/ajt.16324","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2021 American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. All rights reserved. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}